Colitis - cytomegalovirus; Gastroenteritis - cytomegalovirus; Gastrointestinal CMV disease
There is a significant risk of CMV infection in people with no signs of the virus in their blood who receive an organ transplant from a CMV-positive donor. The antiviral drugs ganciclovir (Cytovene) and valganciclovir (Valcyte), taken by mouth before the transplant, can lower your chance of a new infection or reactivation of an old infection in such cases.
People with AIDS who are effectively treated with antiviral therapy are much less likely to get CMV infection.
Young JH, Weisdorf DJ. Infections in recipients of hematopoietic cell transplantation. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2009:chap 311.